NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer immunotherapy combo trial halted early
Disease control TerminatedThis study looked at whether giving two immunotherapy drugs (tiragolumab and atezolizumab) before and after surgery, with or without chemotherapy, is safe and effective for people with a certain type of lung cancer (stage II-IIIB non-small cell lung cancer) that can be removed su…
Matched conditions: NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 29, 2026 01:37 UTC
-
New cancer drug trial shows promise but halted early
Disease control TerminatedThis study tested an experimental drug called TAK-186 in 95 adults with advanced head and neck, lung, or colorectal cancer that could not be removed by surgery. The main goals were to check for side effects and find the best dose. The trial was stopped early, but the results help…
Matched conditions: NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Apr 29, 2026 01:36 UTC